Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis

Autor(es):Mostrar menos -

Pereira, Rafael L. ^[1] ; Buscariollo, Bruna N. ^[1] ; Correa-Costa, Matheus ; Semedo, Patricia ^[1] ; Oliveira, Cassiano D. ^[1] ; Reis, Vanessa O. ^[1] ; Maquigussa, Edgar ^[2] ; Araujo, Ronaldo C. ^[3] ; Braga, Tarcio T. ; Soares, Maria F. ^[4] ; Moura, Ivan C. ^[5] ; Malheiros, Denise M. A. C. ^[6] ; Pacheco-Silva Filho, Alvaro ^{[7, 1]} ; Keller, Alexandre C. ^{[8, 1]} ; Camara, Niels O. S. ^{[1, 9]}

Afiliação do(s) autor(es)

^[1] Univ Fed Sao Paulo, Disciplina Nefrol, Dept Med, Lab Imunol Clin & Expt, BR-04023900 Sao Paulo - Brazil

^[2] Univ Fed Sao Paulo, Disciplina Nefrol, Dept Med, Mol Biol Lab, BR-04023900 Sao Paulo - Brazil

^[3] Univ Fed Sao Paulo, Dept Biofis, BR-04023900 Sao Paulo - Brazil

^[4] Univ Fed Sao Paulo, Dept Patol, BR-04023900 Sao Paulo - Brazil

^[5] Univ Paris 07, INSERM, U699, Paris - France

^[6] Univ Sao Paulo, Dept Patol, BR-05508900 Sao Paulo - Brazil

^[7] Hosp Israelita Albert Einstein, Sao Paulo - Brazil

^[8] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, BR-04023900 Sao Paulo - Brazil

^[9] Univ Sao Paulo, Inst Biomed Sci 4, Dept Immunol, Lab Imunobiol Transplante, BR-05508900 Sao Paulo - Brazil

• Tipo de documento: Artigo Científico
• Fonte: Kidney International; v. 79, n. 11, p. 1217-1227, JUN 2011.
• Citações Web of Science: 16

Resumo

Focal and segmental glomerulosclerosis (FSGS) is one of the most important causes of end-stage renal failure. The bradykinin B1 receptor has been associated with tissue inflammation and renal fibrosis. To test for a role of the bradykinin B1 receptor in podocyte injury, we pharmacologically modulated its activity at different time points in an adriamycin-induced mouse model of FSGS. Estimated albuminuria and urinary protein to creatinine ratios correlated with podocytopathy. Adriamycin injection led to loss of body weight, proteinuria, and upregulation of B1 receptor mRNA. Early treatment with a B1 antagonist reduced albuminuria and glomerulosclerosis, and inhibited the adriamycin-induced downregulation of podocin, nephrin, and alpha-actinin-4 expression. Moreover, delayed treatment with antagonist also induced podocyte protection. Conversely, a B1 agonist aggravated renal dysfunction and even further suppressed the levels of podocyte-related molecules. Thus, we propose that kinin has a crucial role in the pathogenesis of FSGS operating through bradykinin B1 receptor signaling. Kidney International (2011) 79, 1217-1227; doi:10.1038/ki.2011.14; published online 16 March 2011 (AU)

• Processo FAPESP: 08/55125-4 - Imunorregulação em glomerulonefrite: tradução dos achados experimentais para a prática clínica
• Beneficiário: Niels Olsen Saraiva Câmara
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 04/08226-9 - Tolerancia imunologica em transplante renal: papel das celulas reguladoras.
• Beneficiário: Niels Olsen Saraiva Câmara
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 07/07139-3 - Investigando o papel da heme-oxigenase 1 em diferentes processos inflamatórios renais em modelos animais
• Beneficiário: Niels Olsen Saraiva Câmara
• Modalidade de apoio: Auxílio à Pesquisa - Temático